Signaling pathway involved in the pro-apoptotic effect of dopamine in the GH3 pituitary cell line

Neuroendocrinology

Volumn 83, Issue 2, 2006, Pages 77-88

  Jaubert, Arnaud ^a   Ichas, François ^a   Bresson Bepoldin, Laurence ^a,b  

^a INSERM   (France)

^b INSTITUT BERGONIÉ   (France)

Author keywords

Apoptosis; Catecholamine; Dopamine transporter; GH3 cells; Lactotrope; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; CASPASE 3; CYTOCHROME C; DOPAMINE; DOPAMINE TRANSPORTER; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL STRAIN GH3; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; HYPOPHYSIS CELL; MEMBRANE POTENTIAL; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

EID: 33747625842     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094044     Document Type: Article

References (49)

1. Cheng N, Maeda T, Kume T, Kaneko S, Kochiyama H, Akaike A, Goshima Y, Misu Y: Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons. Brain Res 1996;743:278-283.
2. Shinkai T, Zhang L, Mathias SA, Roth GS: Dopamine induces apoptosis in cultured rat striatal neurons; possible mechanism of D2-dopamine receptor neuron loss during aging. J Neurosci Res 1997;47:393-399.
3. Junn E, Mouradian MM: Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases. J Neurochem 2001;78:374-383.
4. Simantov R, Blinder E, Ratovitski T, Tauber M, Gabbay M, Porat S: Dopamine-induced apoptosis in human neuronal cells: inhibition by nucleic acids antisense to the dopamine transporter. Neuroscience 1996;74:39-50.
5. Walkinshaw G, Waters CM: Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinsons disease. J Clin Invest 1995;95:2458-2464.
6. Offen D, Ziv I, Gorodin S, Barzilai A, Malik Z, Melamed E: Dopamine-induced programmed cell death in mouse thymocytes. Biochim Biophys Acta 1995;1268:171-177.
7. Green DR, Evan GI: A matter of life and death. Cancer Cell 2002;1:19-30.
8. Ricci JE, Munoz-Pinedo C, Fitzgerald P, Bailly-Maitre B, Perkins GA, Yadava N, Scheffler IE, Ellisman MH, Green DR: Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain. Cell 2004;117:773-786.
9. De Giorgi F, Lartigue L, Bauer MK, Schubert A, Grimm S, Hanson GT, Remington SJ, Youle RJ, Ichas F: The permeability transition pore signals apoptosis by directing Bax translocation and multimerization. FASEB J 2002;16:607-609.
10. Precht TA, Phelps RA, Linseman DA, Butts BD, Le SS, Laessig TA, Bouchard RJ, Heidenreich KA: The permeability transition pore triggers Bax translocation to mitochondria during neuronal apoptosis. Cell Death Differ 2005;12:255-265.
11. Barzilai A, Daily D, Zilkha-Falb R, Ziv I, Offen D, Melamed E, Shirvan A: The molecular mechanisms of dopamine toxicity. Adv Neurol 2003;91:73-82.
12. Berman SB, Hastings TG: Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J Neurochem 1999;73:1127-1137.
13. Lee FJ, Liu F, Pristupa ZB, Niznik HB: Direct binding and functional coupling of α-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis. FASEB J 2001;15:916-926.
14. Haggi ES, Torres AI, Maldonado CA, Aoki A: Regression of redundant lactotrophs in rat pituitary gland after cessation of lactation. J Endocrinol 1986;111:367-373.
15. Ahlbom E, Grandison L, Zhivotovsky B, Ceccatelli S: Termination of lactation induces apoptosis and alters the expression of the Bcl-2 family members in the rat anterior pituitary. Endocrinology 1998;139:2465-2471.
16. Ben Jonathan N, Hnasko R: Dopamine as a prolactin inhibitor. Endocr Rev 2001;22:724-763.
17. Iaccarino C, Samad TA, Mathis C, Kercret H, Picetti R, Borrelli E: Control of lactotrop proliferation by dopamine: essential role of signaling through D2 receptors and ERKs. Proc Natl Acad Sci USA 2002;99:14530-14535.
18. Gruszka A, Pawlikowski M, Kunert-Radek J: Anti-tumoral action of octreotide and bromocriptine on the experimental rat prolactinoma: anti-proliferative and pro-apoptotic effects. Neuro Endocrinol Lett 2001;22:343-348.
19. Yonezawa K, Tamaki N, Kokunai T: Effects of bromocriptine and terguride on cell proliferation and apoptosis in the estrogen-stimulated anterior pituitary gland of the rat. Neurol Med Chir (Tokyo) 1997;37:901-906.
20. Oyama Y, Hayashi A, Ueha T, Maekawa K: Characterization of 2′,7′-dichlorofluorescin fluorescence in dissociated mammalian brain neurons: estimation on intracellular content of hydrogen peroxide. Brain Res 1994;635:113-117.
21. Smith AL: Preparation, properties, and conditions for assay of mitochondria: slaughter-house material, small-scale. Methods Enzymol 1967;10:81-86.
22. Kim JS, He L, Lemasters JJ: Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem Biophys Res Commun 2003;304:463-470.
23. Cronin MJ, Faure N, Martial JA, Weiner RI: Absence of high affinity dopamine receptor in GH3 cells: a prolactin-secreting clone resistant to the inhibitory action of dopamine. Endocrinology 1980;106:718-723.
24. Johnston JM, Wood DF, Bolaji EA, Johnston DG: The dopamine D2 receptor is expressed in GH3 cells. J Mol Endocrinol 1991;7:131-136.
25. Missale C, Castelletti L, Boroni F, Memo M, Spano P: Epidermal growth factor induces the functional expression of dopamine receptors in the GH3 cell line. Endocrinology 1991;128:13-20.
26. +) and protection by EGF in GH3 cells. Brain Res 1998;794:137-142.
27. Torres GE, Gainetdinov RR, Caron MG: Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci 2003;4:13-25.
28. Graham DG, Tiffany SM, Bell WR Jr, Gutknecht WF: Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol 1978;14:644-653.
29. Hastings TG, Lewis DA, Zigmond MJ: Reactive dopamine metabolites and neurotoxicity: implications for Parkinson's disease. Adv Exp Med Biol 1996;387:97-106.
30. Luo Y, Umegaki H, Wang X, Abe R, Roth GS: Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway. J Biol Chem 1998;273:3756-3764.
31. Kluck RM, Esposti MD, Perkins G, Renken C, Kuwana T, Bossy-Wetzel E, Goldberg M, Allen T, Barber MJ, Green DR, Newmeyer DD: The pro-apoptotic proteins, Bid and Bax, cause a limited permeabilization of the mitochondrial outer membrane that is enhanced by cytosol. J Cell Biol 1999;147:809-822.
32. Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ: Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 1997;139:1281-1292.
33. Falk T, Meyerhof W, Corrette BJ, Schafer J, Bauer CK, Schwarz JR, Richter D: Cloning, functional expression and mRNA distribution of an inwardly rectifying potassium channel protein. FEBS Lett 1995;367:127-131.
34. 3-insensitive mechanisms. Biochem J 1990;268:345-352.
35. Czarnecki A, Dufy-Barbe L, Huet S, Odessa MF, Bresson-Bepoldin L: Potassium channel expression level is dependent on the proliferation state in the GH3 pituitary cell line. Am J Physiol Cell Physiol 2003;284:C1054-C1064.
36. Vaur S, Bresson-Bepoldin L, Dufy B, Tuffet S, Dufy-Barbe L: Potassium channel inhibition reduces cell proliferation in the GH3 pituitary cell line. J Cell Physiol 1998;177:402-410.
37. Bianchi P, Seguelas MH, Parini A, Cambon C: Activation of pro-apoptotic cascade by dopamine in renal epithelial cells is fully dependent on hydrogen peroxide generation by monoamine oxidases. J Am Soc Nephrol 2003;14:855-862.
38. Crompton M: The mitochondrial permeability transition pore and its role in cell death. Biochem J 1999;341:233-249.
39. Kowaltowski AJ, Castilho RF, Vercesi AE: Mitochondrial permeability transition and oxidative stress. FEBS Lett 2001;495:12-15.
40. Valle VG, Fagian MM, Parentoni LS, Meinicke AR, Vercesi AE: The participation of reactive oxygen species and protein thiols in the mechanism of mitochondrial inner membrane permeabilization by calcium plus prooxidants. Arch Biochem Biophys 1993;307:1-7.
41. Aoki A, de Gaisan EO, Pasolli HA, Torres AI: Disposal of cell debris from surplus lactotrophs of pituitary gland. Exp Clin Endocrinol Diabetes 1996;104:256-262.
42. Scheithauer BW, Sano T, Kovacs KT, Young WF Jr, Ryan N, Randall RV: The pituitary gland in pregnancy: a clinicopathologic and immunohistochemical study of 69 cases. Mayo Clin Proc 1990;65:461-474.
43. Gruszka A, Kunert-Radek J, Pawlikowski M: The effect of octreotide and bromocriptine on expression of a pro-apoptotic Bax protein in rat prolactinoma. Folia Histochem Cytobiol 2004;42:35-39.
44. Kanasaki H, Fukunaga K, Takahashi K, Miyazaki K, Miyamoto E: Involvement of p38 mitogen-activated protein kinase activation in bromocriptine-induced apoptosis in rat pituitary GH3 cells. Biol Reprod 2000;62:1486-1494.
45. An JJ, Cho SR, Jeong DW, Park KW, Ahn YS, Baik JA: Anti-proliferative effects and cell death mediated by two isoforms of dopamine D2 receptors in pituitary tumor cells. Mol Cell Endocrinol 2003;206:49-62.
46. Mitsuma T, Rhue H, Hirooka Y, Kayama M, Wago T, Takagi J, Adachi K, Ping J, Ohtake M, Nogimori T, Sakai J: Distribution of dopamine transporter in the rat: an immunohistochemical study. Endocr Regul 1998;32:71-75.
47. DeMaria JE, Nagy GM, Lerant AA, Fekete MI, Levenson CW, Freeman ME: Dopamine transporters participate in the physiological regulation of prolactin. Endocrinology 2000;141:366-374.
48. Fernandez-Ruiz JJ, Esquifino AI, Steger RW, Amador AG, Bartke A: Presence of tyrosine-hydroxylase activity in anterior pituitary adenomas and ectopic anterior pituitaries in male rats. Brain Res 1987;421:65-68.
49. Pisera D, Candolfi M, Navarra S, Ferraris J, Zaldivar V, Jaita G, Castro MG, Seilicovich A: Estrogens sensitize anterior pituitary gland to apoptosis. Am J Physiol Endocrinol Metab 2004;287:E767-E771.